Sjögren syndrome presenting with inflammatory arthritis as a documented systemic manifestation, classified under the M35.0 Sjögren syndrome family of codes.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- General
Documentation tips
What should appear in the chart to support M35.05.
Source · Editorial brief grounded in 6 cited references ↓
- The provider must document both the Sjögren syndrome diagnosis and the inflammatory arthritis as related conditions — a list of separate problem diagnoses without a stated linkage is insufficient for M35.05.
- Specify the inflammatory character of the arthritis: note synovitis, joint swelling, morning stiffness duration, elevated ESR/CRP, or RF/anti-CCP positivity to distinguish from degenerative disease.
- If imaging supports the diagnosis, document findings consistent with inflammatory arthropathy (erosions, periarticular osteopenia, synovial thickening) rather than generic 'arthritis.'
- Record which joints are involved and whether the pattern is symmetric, oligoarticular, or polyarticular — this supports medical necessity for DMARDs or biologics billed alongside this diagnosis.
- Do not conflate sicca symptoms (dry mouth, dry eyes) with the inflammatory arthritis manifestation; each should be addressed in the note, but dry mouth unspecified (R68.2) is excluded from use with M35.0x codes.
Related CPT procedures
Procedure codes commonly billed with M35.05. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M35.05 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Coding M35.00 (Sjögren syndrome, unspecified) when the record clearly documents inflammatory arthritis — M35.05 is the correct, more specific code and M35.00 should only be used when no organ involvement is documented.
- Assigning a standalone inflammatory arthritis code (e.g., M06.9) instead of M35.05 when the arthritis is explicitly attributed to Sjögren syndrome — the manifestation-specific code takes precedence.
- Adding R68.2 (dry mouth, unspecified) as a secondary code alongside M35.05 — this is an Excludes1 violation; dry mouth in Sjögren syndrome is inherent and not separately reportable with M35.0x.
- Using M35.05 for a patient with Sjögren syndrome who also has osteoarthritis — this code is for inflammatory arthritis only; degenerative joint disease should be coded separately with the appropriate M17/M16/M15 code.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M35.05 applies when a patient carries a confirmed Sjögren syndrome diagnosis and also has inflammatory arthritis that is attributable to — or occurring in the context of — that systemic autoimmune disease. This is not the code for coincidental osteoarthritis; the arthritis must be inflammatory in character (synovitis, elevated inflammatory markers, clinical joint findings consistent with autoimmune-driven joint disease). The treating rheumatologist's documentation must explicitly link the two conditions.
This code sits within the M35.0 subcategory, which expanded significantly starting in FY2022 to allow organ- and system-specific coding for Sjögren syndrome manifestations. Before these new codes existed, coders were forced to use the catch-all M35.00 or the outdated M35.0 (sicca syndrome), which obscured the full clinical picture and undermined specificity. M35.05 closes that gap for musculoskeletal involvement.
The tabular instruction at M35.0 directs coders to use an additional code to identify associated manifestations. If the inflammatory arthritis has its own specificity worth capturing — for example, a particular joint pattern — code that separately per the 'code also' convention. Also note the Excludes1 at M35.0: dry mouth unspecified (R68.2) cannot be coded with M35.05, because dry mouth in the context of Sjögren syndrome is inherent to the primary diagnosis, not a separate reportable condition.
Sibling codes
Other billable codes under M35.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01Can M35.05 be used alongside a separate rheumatoid arthritis code?
02When was M35.05 first valid for billing?
03Is M35.05 appropriate for primary versus secondary Sjögren syndrome?
04Should I code the specific joints involved separately when using M35.05?
05Can M35.05 be assigned for inflammatory arthritis that responds to hydroxychloroquine treatment in a Sjögren patient?
06What is the difference between M35.05 and M35.09?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M35-/M35.05
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M35.05
- 04the-rheumatologist.orghttps://www.the-rheumatologist.org/article/changes-in-icd-10-for-sjo%CC%88grens-syndrome/
- 05sjogrens.orghttps://sjogrens.org/sites/default/files/inline-files/ICD-10%208.5x11%20PDF.pdf
- 06files.providernews.anthem.comhttps://files.providernews.anthem.com/4148/MULTI-ALL-CR-054648-24-NMROpt27_2643-Optum-D&C-Tps-Arthrtsldr_FINAL.pdf
Mira AI Scribe
Mira's AI scribe captures the rheumatologist's explicit linkage between the Sjögren syndrome diagnosis and active inflammatory arthritis — including joint distribution, synovitis findings, inflammatory marker results, and morning stiffness duration. That documentation locks in M35.05 over the unspecified M35.00, preventing specificity downcoding and supporting medical necessity for DMARD or biologic therapy authorizations.
See how Mira captures M35.05 documentation